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Abstract: Obesity is a threat to public health worldwide primarily due to the comorbidities 
related to visceral adiposity, inflammation, and insulin resistance that increase risk for type 2 
diabetes and cardiovascular disease. The translational research portfolio that originally described 
these risk factors was significantly enhanced by imaging techniques, such as dual-energy X-ray 
absorptiometry (DEXA), computed tomography (CT), and magnetic resonance imaging (MRI). 
In this article, we briefly review the important contributions of these techniques to understand 
the role of body composition in the pathogenesis of obesity-related complications. Notably, these 
imaging techniques have contributed greatly to recent findings identifying gender and racial 
differences in body composition and patterns of body composition change during weight loss. 
Although these techniques have the ability to generate good-quality body composition data, each 
possesses limitations. For example, DEXA is unable to differentiate type of fat, CT has better 
resolution but provides greater ionizing radiation exposure, and MRI tends to require longer 
imaging times and specialized equipment for acquisition and analysis. With the serious need for 
efficacious and cost-effective therapies to appropriately identify and treat at-risk obese individu-
als, there is greater need for translational tools that can further elucidate the interplay between 
body composition and the metabolic aberrations associated with obesity. In conclusion, we will 
offer our perspective on the evolution toward an ideal imaging method for body composition 
assessment in obesity and weight loss, and the challenges remaining to achieve this goal.
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Introduction
Obesity is an epidemic affecting at least 70 million people in the United States and 
over 300 million individuals worldwide.1 The public health consequences are enormous 
as obesity confers dramatically elevated risk for devastating comorbidities such as 
hypertension, diabetes, cardiovascular disease, liver disease, gallbladder disease, 
musculoskeletal disorders, and several types of cancer, in all population age groups.2 
However, there is a developing appreciation that not all obese individuals and not all 
types of adiposity confer equivalent risk.3 Further, while the evidence indicates an intri-
cate relationship among genotype, ethnicity, body composition, and cardiometabolic 
risk, current methods to characterize body composition have not kept pace with the 
evolving needs of clinicians and researchers. In this article, we briefly review the 
interplay between body composition, obesity, and cardiometabolic risk, with emphasis 
on the areas in which the evidence base is limited by the methods available, and recent 
advances that are likely to significantly impact the future of obesity investigation.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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Body composition and metabolic risk
Obesity-related cardiometabolic risk is often assessed by 
calculating body mass index (BMI), anthropometric measures 
such as waist and hip circumference, or other surrogate 
indicators of total adiposity.4 Although these techniques are 
useful in clinical practice to screen patients for disease risk 
and in large patient populations to determine associations 
with risk for comorbidities, especially when age and gender 
are considered, significant limitations exist. For example, 
data from the National Health and Nutrition Examination 
Survey III show that waist circumference cutoff values that 
correspond to the BMI range indicating overweight and obe-
sity and risk for cardiovascular disease differ by ethnicity.5 
That is, while the waist circumference values associated 
with overweight and obese BMI categories for Caucasian, 
African American, and Hispanic women appear similar, 
the corresponding waist circumference values are lower 
in African American and Hispanic men when compared to 
Caucasian men. In addition, these techniques are often not 
reliable for estimating an individual’s percentage body fat.6 
Moreover, they are unable to assess the amount, type (ie, 
subcutaneous, visceral, interstitial, or yellow marrow), and 
distribution of adipose tissue. Thus, the available clinical 
tools do not identify which components of body composition 
are the most important targets clinically or scientifically.
Consequently, imaging studies were critical in determining 
that the distribution of adipose tissue to central abdominal 
sites (ie, intra-abdominal or visceral adipose tissue [VAT]) 
is important in promoting risk for the inflammation, 
insulin resistance, and dyslipidemia associated with the 
development of comorbidities,7,8 as well as overall mortal-
ity.9,10 Nevertheless, a number of important questions remain. 
For example, there is scientific interest in a more compre-
hensive understanding of the metabolic, physiological, and 
pathophysiological differences among ethnic and life cycle 
groups, as well as a clearer understanding of the subset 
of overweight/obese individuals who have high BMIs and 
percentage body fat without the other features of the meta-
bolic syndrome, ie, the “metabolically healthy but obese” 
phenotype.11–14 Fortunately, a number of additional body 
composition measurement techniques are being utilized in 
obesity research that promise to improve our understanding of 
existing biological concepts and generate new hypotheses.
The need to advance body  
composition techniques
The need for superior tools that provide direct measure of body 
composition becomes even more apparent when comparing 
differences in body composition and cardiometabolic risk 
by demographic factors like gender, age, and ethnicity. For 
example, in comparing males to females, it is well established 
that women have more total fat (adipose tissue), less total 
muscle (lean tissue), and a larger quantity of total adipose 
tissue in the lower trunk and pelvic region.15 However, when 
matched by BMI, men may have more visceral and hepatic 
adiposity.16,17 Clearly, these disparities in adipose tissue 
distribution confer different disease risks. There also exist 
differences in body composition and metabolic profile within 
genders – an effect that is most pronounced in women for 
whom significant differences occur across the life cycle. 
While women in their twenties and thirties are less likely to 
be obese, women at or beyond menopause have increased 
VAT. 18 Moreover, among women of all age groups (adoles-
cent, premenopausal, and postmenopausal), it has been shown 
that those who have a greater proportion of adiposity in the 
upper body have a greater likelihood of being dyslipidemic, 
glucose intolerant, hyperinsulinemic, and insulin resistant 
than those with greater proportion of adiposity in the lower 
body.19 While these risk profiles were determined by dual-
energy X-ray absorptiometry (DEXA), the limitations in this 
technology include an inability to differentiate the type of 
adipose tissue, as will be discussed further.
Additionally, racial and ethnic differences in body 
composition have been identified in males and females. 
In fact, the relationship between abdominal adiposity and 
metabolic risk first came to light from studies using single-
slice computed tomography (CT) scans of lean Japanese 
American males who, despite low BMI, had increased VAT 
and insulin resistance.20 Interestingly, in a study using whole-
body multislice magnetic resonance imaging (MRI), no dif-
ferences were detected in VAT between Asian American and 
Caucasian males after adjustment for age and total body fat. 
In contrast, Asian American females (over 30 years) had a 
higher proportion of VAT compared to Caucasian females.21 
Prior studies also demonstrate puzzling differences in the 
characteristics of adiposity between African Americans and 
Caucasians.5,22–24 For example, African American women 
have less VAT and, therefore, more upper body subcutaneous 
adipose tissue (SAT) than Caucasian women,25,26 but they 
tend to be more insulin resistant.27 In fact, African Americans 
have worse cardiometabolic disease profiles overall: a higher 
incidence of hypertension, twice the prevalence of diabetes, 
and 2- to 3-fold greater incidences of coronary artery disease 
and stroke. Yet, greater upper body obesity is associated 
with mortality in Caucasians but not in African Americans.28 
Hence, racial disparities in obesity and its comorbidities are Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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not solely related to the anatomical location of fat (ie, upper 
vs lower body adiposity) or simply the relative proportion 
of VAT to SAT. This discrepancy has been recognized in the 
adjustments that have recently been made in waist circum-
ference cutoffs to accommodate differences by race and 
ethnicity for cardiovascular risk.29
Overall, synthesis of published findings such as these 
suggest that while a number of potentially important findings 
have been uncovered, an underlying unifying mechanistic 
explanation has yet to emerge. We hypothesize that this gap 
in the evidence base may be related to the relative strengths 
and weaknesses of the body composition techniques that 
populate the literature. Hence, more sensitive methods 
to quantify metabolically active adipose depots promise 
to enhance mechanistic studies and our understanding of 
observed outcomes.
Beyond adipose tissue: ectopic fat
While absolute adipose mass, and perhaps the more 
insulin-resistant VAT, confers significant metabolic risk, the 
accumulation of fat in nonadipose tissues (ie, lipid within 
skeletal muscle and organs such as the liver, pancreas, and 
heart), for which in vivo quantification has been best achieved 
by advanced tools such as MR spectroscopy (MRS), is 
increasingly recognized as a mediator of insulin resistance 
and inflammation.30–34 In fact, in obesity, the association 
between intramyocellular lipid and insulin resistance is 
stronger than with VAT.33 It is also noteworthy that in states 
of reduced adipose tissue mass, eg, lipodystrophy, there is 
increased ectopic fat, insulin resistance, and diabetes.35
In conjunction with the focus on intramyocellular lipid, 
a novel fat depot existing between muscle bundles and 
beneath the muscle fascia, termed intermuscular adipose 
tissue (IMAT), may also reveal significant metabolic 
information.36 Interestingly, African Americans, who have 
more skeletal muscle than Caucasians, also appear to have a 
greater amount of IMAT. This disparity in ectopic fat appears 
most pronounced at higher levels of adiposity.36,37 Thus, it is 
conceivable that increased skeletal muscle and IMAT volume 
at least partially account for the observed differences among 
ethnicities in the insulin response to glucose.38 However, 
the extent to which IMAT functions in onset of insulin 
resistance remains to be further investigated. We suggest 
that a full understanding of the role of IMAT in health and 
disease will arise as a consequence of improved methods to 
quantify this lipid depot.
Similarly important, the accumulation of intrahepatic fat 
has serious implications due to its role in the pathogenesis 
of insulin resistance, dyslipidemia, steatosis, steatohepatitis, 
and progression to diabetes, coronary heart disease, and liver 
failure.39 While the current gold standard for diagnosis of 
“fatty liver” is liver biopsy, intensive efforts are underway to 
standardize both CT and MRI methods to quantify liver fat. 
Of course, MRS has also been used to understand liver lipid 
metabolism. Nevertheless, one of the limitations of current 
imaging methodologies, and an important opportunity to 
improve the scientific evidence base, would be the ability to 
incorporate measures of ectopic fat more widely in clinical 
and research settings.
Body composition changes  
during weight loss
Few studies have investigated how weight loss influences body 
composition. A classic model by Forbes40 predicts that during 
voluntary weight loss, the relative proportion of body mass 
loss would be approximately 80% fat and 20% lean tissue 
mass. The composition of body mass loss is likely influenced 
by many factors, including genetics,41 gender, ethnicity, aging, 
degree of energy deficit,42 dietary macronutrient composition 
and substrate utilization,43 hormonal status,44 degree and type 
of physical activity,45 comorbid disease states, and perhaps 
the type of weight loss intervention (dietary, pharmaceuti-
cal, or surgical). For example, it is expected that while males 
would lose proportionately more fat-free mass compared to 
females, they also lose more VAT.46 In response to caloric 
restriction, it has also been observed that Caucasian females 
lose approximately 50% more VAT and less SAT than African 
Americans despite similar total weight loss.47 Intriguingly, 
these authors observed no significant differences between 
Caucasian and African American females with regard to 
improvements in insulin sensitivity and lipid profiles.48 While 
this finding appears to contrast with much other data, it 
suggests that the metabolic benefits of weight loss were not 
directly related to changes in the relative change in VAT and 
SAT, but it should be noted that the women studied were 
overweight, not obese, and premenopausal, and there was 
no assessment of the degree of ectopic fat and its role in the 
measured outcomes.
With involuntary weight loss, ie, that which occurs dur-
ing chronic illness, injury, or malignancy, there is often an 
aberration in the proportional changes in body composition, 
yielding an excessive loss of lean tissue, and sometimes 
preservation of adipose tissue mass. For example, in 
studying overweight head and neck cancer patients treated 
with concomitant chemoradiation, we detected a body mass 
loss that was 72% lean and only 28% fat.49 Further, when Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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negative energy balance is combined with reduced physical 
activity, such as that occurring with bed rest, space flight, or 
sometimes physiological aging, accelerated protein turnover 
results in greater lean tissue loss.50 From a metabolic perspec-
tive, this decrease in lean mass should have the detrimental 
consequence of impaired insulin sensitivity.
In reality, few populations have been prospectively 
studied with respect to the relative changes in fat vs lean 
tissue mass during voluntary or involuntary weight loss, not 
to mention changes in the type, distribution, and location of 
lipid burden. While it is expected that weight loss reduces 
fat and lean mass from various body depots, the mechanistic 
basis for such changes, whether adaptive or maladaptive, 
has not been clarified, and existing studies have utilized 
isotope-labeled tracer techniques that are not applicable 
outside highly sophisticated research settings.51 We suggest 
that the successful design of studies to better understand the 
interactions between body composition and cardiometabolic 
risk, and those capable of wholly assessing the efficacy of 
weight loss interventions, requires advanced techniques that 
measure not only the amount and type of adipose tissue but 
also its anatomical distribution. Moreover, ideal techniques 
must be capable of quantifying ectopic fat.
Current imaging methods
Imaging methods are considered to be the most accurate tools 
for measuring adipose tissue in body tissues and organs in 
clinical research.52,53 Imaging methods provide information 
about the spatial distribution of adipose tissue by exploiting 
differences in the imaging properties of different tissues and 
organs seen as 2-dimensional (2D) projections with DEXA 
scans or 2D multislice and 3-dimensional (3D) anatomical 
datasets with CT and MRI. Thus, regional differences in tissue 
X-ray absorption properties or MRI signal characteristics pro-
vide contrast in images that allow lean and adipose tissue to 
be distinguished and their respective volumes to be calculated. 
The accuracy of distinguishing tissue types depends on the 
degree of tissue contrast and the spatial resolution inherent 
to imaging modalities, which in turn depend primarily on 
the sensitivity and speed of acquiring images. Yet, no single 
method commonly employed accounts for all the factors   
(ie, amount, type, and distribution) that we and others 
hypothesize as highly relevant to outcomes of interest. Fur-
ther, all methods contribute some form of error or bias that 
is usually related to assumptions about body composition 
that may not hold across different population groups and 
clinical   scenarios.54 The pros and cons of the three common 
state-of-the-art imaging techniques for whole body measure-
ment, ie, DEXA, CT, and MRI,55 will be contrasted in the 
following sections, with key characteristics summarized in   
Table 1.
However, before comparing body composition techniques, 
we must first recognize the important construct of categoriz-
ing body composition components into 5 distinct levels, ie, 
atomic level, molecular level, cellular level, tissue-systems 
level, and whole body level. While DEXA estimates body 
composition components at the molecular level (eg, fat 
mass), CT and MRI assess body composition components 
at the tissue-systems level (eg, adipose tissue). As this is 
not the focus of this article, we call the readers’ attention to 
several excellent reviews further describing this fundamental 
concept.66–68
Table 1 Key characteristics of the most common imaging techniques used to quantify body composition
Imaging technology DEXA Quantitative X-ray CT MRI
Year (first applied to body composition) 198156 197957 198458
images acquired Coronal 2D projection 2D single-slice 2D single-slice 
2D multislice 
2D multislice 3D image volumes
Coefficient of variation Total body fat: 2%–3%59 SAT: 0.50%60 Total body fat: 2.90%61
vAT: 2.32%55
vAT: 1.20%60 (multislice acquisition) SAT: 2.25%55
TAT: 1.01%55
Scan time (whole body) 10–20 min Several seconds per slice 10–20 min
Resolution 1 mm × 1 mm62 1.8 mm × 1.8 mm × 5 mm55 2 mm × 2 mm × 8 mm63
Radiation dose 5–7 μSv59 2.7–10 mSv64,65 (whole body) None
Research cost per scan Moderate (∼$135) High (∼$500) High (∼$500)
Availability Moderate Limited Limited
Abbreviations:  DeXA,  dual-energy  X-ray  absorptiometry;  CT,  computed  tomography;  MRi,  magnetic  resonance  imaging;  2D,  2-dimensional;  3D,  3-dimensional;   
SAT, subcutaneous adipose tissue; vAT, visceral adipose tissue; TAT, total adipose tissue.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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Dual-energy X-ray absorptiometry
Replacing dual-photon absorptiometry (DPA) in 1989, 
DEXA was designed initially to estimate whole body and 
regional bone mineral density. DEXA uses an X-ray tube 
combined with a switch or filter to generate a larger flux of 
photons than DPA, yielding greater precision and shorter 
scan times.62 Typical DEXA scanners are composed of a flat 
table on which the subject lays supine with an X-ray generator 
under the table and a movable X-ray detector above that 
translates in the direction of head to foot. The X-ray source 
moving beneath the subject emits a pencil beam or fan beam 
of X-rays at two energy levels, typically 40/70 or 43/110 keV 
(depending on the manufacturer), which allow algorithms 
for the quantification of two distinct tissue types. While one 
energy level is well absorbed by soft tissue, ie, fat, the other 
is well absorbed by denser tissue, ie, bone. Hence, a tech-
nically well-acquired DEXA scan provides a reasonable 
estimate of total and regional (trunk, legs, and arms) fat and 
fat-free mass using proprietary equations based on tissue 
density and X-ray biophysics. Since total and regional fat 
estimated by DEXA is the sum of all fatty elements of soft 
tissue, a limitation of DEXA is the inability to differentiate 
adipose tissue and, thus, the inability to compare amounts 
or changes in VAT vs SAT.
Additionally, the trunk region determined by DEXA 
typically includes chest, abdomen, pelvis, and, thus, an inabil-
ity to more specifically quantify the types of fat in specific 
body compartments. This can be particularly problematic in 
studying obese women as the determination of trunk fat by 
DEXA includes pelvic and gluteal fat, thereby confounding 
estimation of metabolic risk.69 Although some body composi-
tion researchers delineate the central abdominal region using 
DEXA by manually adjusting the trunk margins to include 
only the area from L2 to L4 vertebrae, this assessment still 
includes SAT.70 Further, defining the region of interest 
determined by DEXA is well-known to be operator depen-
dent. Notably, with manipulation of the region of interest, 
it has been observed that DEXA estimates total abdominal 
adipose tissue better in nonobese (vs obese) persons.71
Nevertheless, percentage trunk fat estimated by DEXA 
has been positively correlated (r = 0.77) with VAT determined 
by CT in a sample of 206 lean and obese women.72 However, 
weaker correlations have been observed, supporting our 
hypothesis that while a number of techniques perform well 
across larger populations, there remains significant intrain-
dividual variability. In another study, DEXA-estimated fat 
was correlated with MRI quantification of adipose tissue, 
but in 877 HIV+ and 260 healthy adults, DEXA significantly 
overestimated total and regional fat mass (P , 0.0001).73 
Importantly, as the amount of body fat mass increased 
(ie, greater adiposity), the DEXA overestimates were 
proportionally larger, which would confound assessment of 
metabolic risk.
Mechanisms explaining some of these limitations of 
DEXA include variation based on the depth of tissue being 
analyzed. It appears that the anteroposterior thickness of 
a subject at #20 cm does not violate the assumption of 
density on which DEXA algorithms are based, and thus, 
at this thickness, overestimate of fat mass was #4% and 
overestimate of fat-free mass was #2%.74 However, at higher 
body thickness, DEXA provides greater error.73 This is an 
important consideration as most obese subjects will have 
anteroposterior thickness .20 cm.
Similarly, determination of lean soft tissue mass by 
DEXA (technically fat-free mass) suffers limitations. As lean 
mass in extremities is mostly muscle, DEXA-derived lean 
mass can predict skeletal muscle mass, although amounts 
are overestimated,75 most likely because DEXA requires the 
potentially inaccurate assumption that there is a fixed propor-
tion of muscle mass in the limbs. Hence, in a heterogeneous 
population of subjects with differing body composition, this 
assumption could confound the accuracy of skeletal muscle 
mass determination. Another fundamental assumption is 
that the soft tissue is normally hydrated (as DEXA does 
not estimate body water content). However, the presence of 
underhydration or overhydration is common in acute and 
chronic disease states, including obesity, and within certain 
life cycle groups, such as young children and older adults. 
It has been estimated that a 5% change in the water content 
of the fat-free mass influences DEXA estimates of body 
fat about 2.5%.76 Even drinking water before scanning can 
increase estimates of total and lean mass.77
Therefore, depending on the manufacturer, hardware, 
software, and operator, different DEXA devices show 
differences in assessment of bone mineral content by ±19%, 
fat mass by ±7%, and lean mass by ±4%.73,78,79 Nevertheless, 
the widespread availability and relative low expense of 
DEXA compared with more sophisticated imaging tools such 
as CT and MRI assure that DEXA will continue to be impor-
tant for assessing body composition in health and disease, 
and therefore, it is scientifically important to understand its 
relative limitations.
More direct anatomical measures of both adipose and 
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to resolve adipose from nonadipose tissue, although they are 
not typically used to detect the lipid burden within muscle 
unless additional spectroscopic methods are added to the 
procedure. A key advantage of these imaging techniques in 
body composition and obesity research is the ability to assess 
in vivo tissue type and distribution and the future potential 
for determining organ composition.
CT scan
CT systems are typically composed of a cylindrical housing 
unit that contains an X-ray tube source rotating in a plane 
perpendicular to the subject. Individuals enter the system 
on a moving table that travels through the gantry opening. 
The finite diameter of the gantry opening may limit the size 
of subjects that can be scanned. Like DEXA (although at 
much higher radiation doses), the X-ray source produces a 
pencil- or fan-shaped beam that passes through the body. The 
application of CT to body composition was first demonstrated 
in 1979 when the cross-sectional area of mid-arm muscle 
mass was quantified in persons ranging from 60% to 120% 
of ideal body weight.57 During the 1980s, body composition 
research was further advanced when CT was used to quantify 
adipose tissue.80,81 These initial studies used a single-slice 
technique typically at the level of the umbilicus; now mul-
tislice techniques are most often utilized.
CT scans typically generate multiple 2D anatomical 
images that may form noncontiguous or contiguous 3D image 
volumes at a high resolution from which the difference in den-
sity between adipose vs nonadipose tissue can be quantified 
using tissue segmentation image analysis. From a CT image, 
tissue type can be distinguished, or segmented, based on CT 
number, which represents the electron density of the tissue 
within a particular volume element (voxel). CT numbers are 
expressed on a scale using Hounsfield units (HU), where 
HU = 0 for water and HU = −1,000 for air. CT numbers 
for adipose tissue range from −190 to −30 HU, whereas CT 
numbers for lean tissue range from 30 to 100 HU. Thus, CT 
provides both exquisite spatial and tissue-type resolution.64 
Once segmented (manually or automatically), tissue area can 
be calculated using known in-plane dimensions of the CT 
image and tissue volume can be calculated using the slice 
thickness for a single slice, or a volume estimate can be 
made using the average cross-sectional area of two nearby 
slices and the distance between slices. For a contiguous set 
of slices, the volume calculation for each adjacent slice pair 
can be summed to yield a total volume.52 The total adipose 
tissue can then be estimated by using density values avail-
able in the literature, eg, 0.923 kg dm−3.60 Recent studies 
have demonstrated excellent intraobserver and interob-
server reproducibility of CT-based quantification of VAT 
and SAT.
While CT is excellent for segmenting adipose from 
nonadipose tissue, it is incapable of detecting ectopic fat. 
Further, there can be significant errors associated with the 
estimation of tissue and organ margins and reconstruction of 
volumetric data from noncontiguous 2D multislice datasets. 
Although a whole body protocol incorporating 28 slices 
positioned at specific locations has been reported,60 the 
time required for image post processing can be substantial 
for multislice acquisitions, taking up to 3 hours to analyze 
28 slices.55
Most importantly, the amount of radiation exposure from 
CT limits its use in longitudinal data collection where serial 
measures would be necessary, and in vulnerable populations, 
such as growing children and women of child-bearing age. 
Typical protocols have limited the number of image slices to 
minimize radiation exposure. Indeed, the safety of radiation 
exposure from CT has received greater scrutiny from 
scientists recently because of the potential risk for free radical 
damage and cancer from radiation doses, which would vary 
in measuring whole body composition depending on the size 
of the subject and the type of CT equipment used.82 While 
no large epidemiological studies establishing the relative risk 
have been completed yet, recommendations have been made 
that MRI replace CT where possible.
MR imaging
The utility of MRI for assessing adipose tissue has been 
recognized for some time, but the low sensitivity and tech-
nical challenges including long scan duration have limited 
its broader utilization. Hence, early adopters used a small 
number of slices to assess adipose tissue.58,83 This evolved to 
the collection of multiple 2D slices from which whole body 
adipose and lean tissue volumes and masses were estimated 
using linear interpolation across consecutive slices.61,84,85 
The movement from a few slices toward whole body imag-
ing was further advanced with the recognition in 1998 that 
single-slice results from various body depots had significant 
variability in total and VAT across the range of BMI, which 
could not be predicted from determination of SAT or standard 
anthropometry.84
Although the contrast in CT images is generated by 
differences in the X-ray absorption properties of different 
tissues, the contrast in MRI scans depends on tissue-specific 
MR properties, such as proton density (ie, density of 
hydrogen atoms) and longitudinal (T1) and transverse Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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(T2, T2*)   relaxation times. One or more of these proper-
ties can be exploited to generate contrast between lean and 
adipose tissues. For example, differences in the rate at which 
the magnetization of protons in fat and water return to equi-
librium following an MR excitation (differences in fat and 
water T1s) leads to characteristic differences in intensities of 
the MR signal from fat (brighter) and water (darker) tissues 
in the T1-weighted MR images. This contrast in MRI scans 
can be exploited to provide greater discrimination of adipose 
and lean tissues and to provide improved estimates of ectopic 
lipid burden. Recently, measurement of adipose tissue using 
a whole-body T1-weighted imaging protocol was used to 
correlate VAT with insulin sensitivity in subjects at risk for 
type 2 diabetes.85 In this study, T1-weighted 3D whole body 
imaging was reported to have taken 20–25 minutes per sub-
ject. When shorter imaging times are preferred, fewer slices 
may be acquired to cover the entire body – as in a recently 
reported approach in which 10-mm-thick image slices were 
acquired every 40 mm of the whole body, but only 20% of 
the full body data was captured.73
Since MRI does not rely on ionizing radiation, it can be 
used in vulnerable population groups and in longitudinal 
studies requiring serial measures. And, MRI techniques have 
a slightly higher reproducibility than CT scans. For example, 
in healthy adults who had repeat scans during a 4-hour period, 
the coefficient of variation for VAT assessment by MRI was 
10.6% compared with 12.8% with CT.86 Improvements in 
MRI is evident in the more precise assessment of variability 
that has been determined using human cadavers and 
abdominal dissections, which showed tighter coefficient of 
variation ranging from 1% to 10% for SAT and from 6% to 
11% for VAT measurements,87 and from 0.2% to 2.3% for 
appendicular skeletal muscle mass measurement.67
In addition to T1 differences, the different chemical 
environment of protons in water and in triglyceride fatty acid 
chains leads to small but measurable differences in their MRI 
resonance frequencies. The resonance frequency differences 
can be detected directly using MR spectroscopic techniques 
and indirectly with an imaging approach commonly known as 
the Dixon method. The Dixon method, introduced in 1984,88 
uses repeated acquisitions of the evolving MRI signal to 
capture images with echo times when water and fat signals 
are “in phase” (signals add) and “out of phase” (signals 
subtract). The MR signal echo time describes the time delay 
of signal acquisition after exciting the fat and water protons 
with radio frequency pulses. Pure water and fat images can 
theoretically be reconstructed from the sum and difference 
images to yield separated fat and water images, respectively. 
The ratio of the fat to water signals at each point in the image 
is used to classify the tissue at that location as either adipose 
or lean. However, the separation of fat and water signals using 
the Dixon method can be confounded by imperfections in the 
scanner’s static magnetic field (ie, B0 inhomogeneity), which 
causes ambiguities in the classification of MR signal as fat or 
water and error in the estimation of adipose and lean tissue 
volumes. Additionally, in areas with approximately equal 
fat and water signal intensities, the signal cancellation can 
impair estimation of the fat fraction.89
To address this problem, the Dixon method has been 
enhanced by increasing the number and modifying the 
spacing between the individual images acquired at different 
echo times.90 Along with other refinements to the Dixon 
method over the past 2 decades,91 such as using optimized 
asymmetric echo spacing89 and detailed modeling of 
differences in the patterns of MR signal decay of the fat and 
water components, more accurate estimates of adipose tissue 
and water within tissues have been produced.92
Because some protocols do not image the entire body, 
they are subject to various sources of error. First, when 
studying a body depot, such as the abdominal compartment, 
a practical challenge is how best to match slice positions 
across individuals with varying body habitus. Second, once 
a positioning algorithm has been established, there remains 
scan-to-scan variability in precision of slice placement. Third, 
even if slices were perfectly and reproducibly positioned, 
there are significant errors associated with the interpolation 
of volumes in unsampled interslice regions. This could be 
particularly problematic in longitudinal studies, and this 
artifact in interpolating volumes would be particularly acute 
in the visceral compartment where adipose tissue is hetero-
geneously distributed among other visceral organs.93
While using similar biophysical approaches as MRI 
related to chemical shift, MRS separates, characterizes, and 
records chemical signals within a single voxel to provide 
information about the actual composition of chemicals or 
metabolites within the image. The peaks of the metabolites 
are identified by their frequency and expressed as a shift in 
the frequency relative to a standard, typically water, which is 
highly concentrated in human tissues. This so-called chemical 
shift is expressed in parts per million (ppm). Thus, water is 
located at 4.26 ppm, whereas the dominant fat signal (from 
aliphatic protons) is located at approximately 1.25 ppm.95 
Being independent of MR magnetic field strength, it allows 
comparisons of MR spectra obtained from imaging systems 
of different field strengths (eg, 1.5T vs 3T). The MR spectrum 
from a volume of tissue contains peaks at frequencies Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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characteristic of the chemical (eg, water and fat) constituents. 
The relative areas of these peaks, after correction for the 
number of hydrogen atoms per molecule and differences in 
T1, T2, etc, provide the relative concentrations of the different 
chemical species.
In human metabolic studies, MRS can yield greater 
chemical specificity than MRI, particularly in lean tissues 
(such as the liver), but this generally comes at the expense 
of spatial resolution and anatomical coverage. Furthermore, 
MRS is more sensitive to magnetic field inhomogeneities and 
motion (respiratory, visceral, bulk body) artifacts, making 
MRS especially challenging when assessing intra-  abdominal 
tissues. For example, in the case of the pancreas, an 
irregularly shaped organ with a small volume, the larger voxel 
size required for MRS can compromise the tissue specificity 
of the MRS measurement.96 Like with MRI, correcting for 
artifacts such as respiratory motion using automated post 
processing is becoming more available. Ultimately, the infor-
mation obtained by MRS is complimentary to that obtained 
by MRI, and as these methods continue to evolve, it will be 
ideal to be able to extract both types of information from a 
single MR dataset.
It is exciting that highly promising conceptual and 
technological advancements involving complete sampling 
of body compartment data, and thus, eliminating the need 
for interpolation, and minimizing the challenges associated 
with positioning have occurred over the past 2 years. In 2009, 
a method for fully automated assessment of total adipose 
tissue was reported, which employed a continuously moving 
table, an optimized multi echo data acquisition sequence (an 
evolution of the Dixon method, termed “fat–water imaging”), 
and a computer algorithm for fully automated analysis of 
the data to yield total, visceral, and SAT measures.63 Such 
automated segmentation of adipose tissue compartments 
is critically important for widespread application of MR 
fat–water imaging. Strategies for segmentation include 
morphological approaches63 and those based on more 
advanced image processing such as fuzzy connectedness.94 
Quantification of adipose tissue volume acquired on a voxel-
by-voxel basis with such techniques are more accurate and 
robust.
Perspective on the promise of imaging  
to obesity, body composition,  
and metabolic disorders
The application of novel methods to enhance imaging 
technology for improved assessment of human body 
composition promises to enhance our understanding of the 
mechanisms, physiology, and pathophysiology of obesity-
related comorbidities. This is especially critical in the current 
health care environment of increased acuity of care combined 
with substantial disparities in access to care and the need to 
contain health care resource use. As the presence of comor-
bidities varies among the obese, it is most important to be 
able to identify and target those obese individuals who are 
at risk for type 2 diabetes and cardiovascular disease. Yet, 
current methods of identifying these individuals have not 
achieved standardization, and thus, there is still no consensus 
on specific criteria to categorize obese phenotypes.
An ideal imaging method that incorporates the charac-
teristics of being noninvasive, rapid, sensitive, and specific 
would have significant utility in addressing the limitations 
of current methodologies discussed earlier and enhance our 
understanding of metabolic risk in various populations. It 
is also critical that such a method be convenient and cost 
effective for use in both clinical and research settings. While 
calculating the costs of DEXA, CT, and MRI solely by the 
actual amount of time spent scanning makes these techniques 
comparable, the total costs remain significantly different 
because of the time and sophistication of methods needed 
to analyze the acquired data (Table 1). Nevertheless, a mov-
ing table fat–water MRI technique that enables acquisition 
of an entire noninterpolated whole body dataset, which is 
readily segmented using automated analysis techniques and 
could be performed on standard 1.5T or 3T body imagers in 
the range of 30 minutes or less, could meet this need, espe-
cially if the dataset acquired could also be used to extract 
the type of functional information provided from MRS of   
ectopic fat.
If the promise of such advances in imaging methodology 
can be met, coupling of these data with measures more 
typically utilized in clinical practice and research, such as 
blood pressure, lipid and liver enzyme profiles, biomarkers 
of inflammation (eg, high sensitivity c-reactive protein and 
PAI-1), and indicators of glucose metabolism and insulin 
sensitivity, would enable the development of more precise 
predictive risk models. Upon standardization, such a method 
could be utilized to distinguish differences among obese 
subjects across the span of gender, age, ethnicity, and BMI 
categories in both adipose and lean tissue amounts, types, 
and distribution in any body depot. Furthermore, and perhaps 
most critically, such methods might offer the potential to 
streamline therapeutic targets and offer critical insights into 
the efficacy of weight loss and other interventions designed 
to reduce metabolic risk, as well as increasing the utilization 
of body composition in obesity research.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 submit your manuscript | www.dovepress.com
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